Zeskind Benjamin J. 13D and 13G filings for Immuneering Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-17 4:13 pm Purchase |
2024-12-31 | 13G | Immuneering Corporation IMRX |
Zeskind Benjamin J. | 3,978,168 12.800% |
291,026 (+7.89%) |
Filing |
| 2024-01-16 4:37 pm Purchase |
2023-12-31 | 13G | Immuneering Corporation IMRX |
Zeskind Benjamin J. | 3,687,142 12.600% |
191,356 (+5.47%) |
Filing |
| 2023-02-08 4:15 pm Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
Zeskind Benjamin J. | 3,495,786 13.100% |
138,507 (+4.13%) |
Filing |
| 2022-02-10 5:21 pm Purchase |
2021-12-31 | 13G | Immuneering Corporation IMRX |
Zeskind Benjamin J. | 3,357,279 12.700% |
3,357,279 (New Position) |
Filing |